Key result
Aortic valve replacement with the Perceval S sutureless valve for prosthetic valve endocarditis was associated with a 20% in-hospital mortality rate (1 of 5 patients).
Why the study?
Is aortic valve replacement with sutureless Perceval S bioprosthesis feasible and safe in patients with prosthetic valve endocarditis?
Observational (n=5)
Is aortic valve replacement with sutureless Perceval S bioprosthesis feasible and safe in patients with prosthetic valve endocarditis?
Aortic valve replacement with the Perceval S sutureless valve is a feasible and potentially safe option for patients with prosthetic valve endocarditis based on a small initial experience.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for sutureless valves in prosthetic valve endocarditis; should not yet change practice.
BACKGROUND: The objective of this study is to evaluate results of the initial experience with sutureless Perceval S for active prosthetic valve endocarditis (PVE). MATERIALS AND METHODS: From October 2012 to April 2014, f: ve patients underwent surgery for aortic PVE with Perceval S bioprosthesis. RESULTS: There was one in-hospital death (20%). Echocardiography performed at discharge showed excellent hemodynamic performance of Perceval S bioprosthesis. CONCLUSION: Aortic valve replacement with Perceval S sutureless valve in patients with PVE is a feasible and safe procedure, associated with low in-hospital mortality and good hemodynamic performance of the prosthesis.
No takes yet. Share an insight, caveat, or question.
Miceli et al. (2015) conducted an observational in Prosthetic valve endocarditis (n=5). Sutureless Sorin Perceval S Aortic Prosthesis was evaluated on In-hospital death. Aortic valve replacement with the Perceval S sutureless valve for prosthetic valve endocarditis was associated with a 20% in-hospital mortality rate (1 of 5 patients).
Synapse has enriched 10 related papers. Consider them for comparative context: